STOCKHOLDERS EQUITY

9 Months Ended

Sep. 30, 2013

STOCKHOLDERS EQUITY [Text Block]

NOTE D – STOCKHOLDERS’ EQUITY

As a result of the reverse merger (see Note A item 6), the common stock of Cybrdi-Maryland has been cancelled and converted into shares of common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of Carton’s common stock to the Cybrdi shareholders. As of September 30, 2013 and December 31, 2012, the Company had 120,225,323 shares issued and outstanding, respectively.

As of September 30, 2013, the balance sheet included total equity of $4,112,710, of which $953,325 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.

As of September 30, 2012, the balance sheet included total equity of $4,112,710, of which $953,325 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying. As of September 30, 2012, the balance sheet included total equity of $4,606,147, of which $1,091,375 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.